Results 41 to 50 of about 36,688 (264)

Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study

open access: yesFrontiers in Oncology, 2020
Purpose: Adjuvant chemotherapy following resection is recommended by clinical practice guidelines for all patients with pancreatic ductal adenocarcinoma (PDAC).
Yuchao Zhang   +7 more
doaj   +1 more source

Flowchart of patient selection from the SEER database. [PDF]

open access: yes
Flowchart of patient selection from the SEER database.
Xia Cheng (1784338)   +6 more
core   +1 more source

Pulmonary marginal zone lymphoma: A single center experience and review of the SEER database [PDF]

open access: yes, 2008
Pulmonary marginal zone lymphoma is a rare disease arising from bronchial-associated lymphoid tissue (BALT). There is limited information on clinical presentation, natural history and treatment of this type of lymphoma.
A. Stefanovic   +11 more
core   +1 more source

Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database [PDF]

open access: yes, 2011
Background Olfactory Neuroblastoma is a rare malignant tumor of the olfactory tract. Reports in the literature comparing treatment modalities for this tumor are limited.
Merzianu Mihai   +13 more
core   +1 more source

Validating the ACOSOG Z0011 Trial Result: A Population-Based Study Using the SEER Database [PDF]

open access: yes, 2020
The Z0011 trial demonstrated that axillary lymph node dissection (ALND) could be omitted in spite of 1–2 metastatic sentinel lymph nodes. This study aimed to validate the results on a population-based database.
Kim, Su-jin   +15 more
core   +1 more source

A prognostic nomogram for predicting overall survival in colorectal mucinous adenocarcinoma patients based on the SEER database [PDF]

open access: yes, 2023
A nomogram was constructed to predict the survival of patients with colorectal mucinous adenocarcinoma based on data extracted from the Surveillance, Epidemiology and End Result (SEER) database. Data collected between 2010 and 2018 were obtained from the
Hong, Guodai   +15 more
core   +2 more sources

A Comparison of the Current N2 Classification and a Modified N2 Categorization in TNM Staging of Esophageal Cancer Patients

open access: yesFrontiers in Oncology, 2021
ObjectiveTo compare the effectiveness of the current N classification and a modified N2 categorization in TNM staging of esophageal cancer (EC) patients.MethodologyA total of 2753 EC patients were enrolled in the study: 2283 EC patients from the ...
Kexing Xi, Kexing Xi, Hui Yu, Hui Yu
doaj   +1 more source

Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States.

open access: yesPLoS ONE, 2019
This study aimed to identify the trends in the incidence of thymic cancer, i.e., thymoma, thymic carcinoma, and thymic neuroendocrine tumor, in the United States.
Chun-Hsiang Hsu   +5 more
doaj   +1 more source

Competing‐risks nomograms for predicting cause‐specific mortality in parotid‐gland carcinoma: A population‐based analysis

open access: yesCancer Medicine, 2021
Introduction Parotid‐gland carcinoma (PGC) is a relatively rare tumor that comprises a group of heterogeneous histologic subtypes. We used the Surveillance, Epidemiology, and End Results (SEER) program database to apply a competing‐risks analysis to PGC ...
Fengshuo Xu   +7 more
doaj   +1 more source

Rational Use of Herbal Products in Pediatric Patients Treated With Anticancer Drugs in the European Union

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction The use of herbal medical preparation (HMP) is rising among pediatric oncology patients, often to manage treatment‐related symptoms. Their effectiveness remains uncertain, and the risk of herb–drug interactions is underestimated.
Orianne Mahot   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy